The Transcripts: Takeaways from CVS, Teladoc, and DaVita Earnings

The Transcripts: Takeaways from CVS, Teladoc, and DaVita Earnings

In our first earnings roundup, we looked at the fourth-quarter and full-year 2022 financial performance of three major publicly traded companies in the managed care market. They achieved positive operating and financial results for 2022, with some even surpassing their expectations for the year. To read more about earnings results in the managed care market, you can read that spotlight on the LevinPro HC platform here. This week, we’re looking at companies in other healthcare verticals, including retail, dialysis and eHealth. CVS Health Corporation, Teladoc Health, Inc. and DaVita Inc are all prominent in their respective fields, and their financial performance can reveal much about the... Read More »
DaVita and Optum Make It over the Finish Line

DaVita and Optum Make It over the Finish Line

It’s been a long road for DaVita Inc. (NYSE: DVA) and Optum (NYSE: UNH), but the deal is finally done. On June 19, 2019, the Federal Trade Commission approved Optum’s acquisition of DaVita Medical Group, a $4.9 billion deal when it was announced on December 6, 2017. A year later, the final price was renegotiated down to $4.34 billion. At the time of the initial announcement, Optum agreed to pay cash for the medical group and its network of nearly 300 medical clinics, 35 urgent care centers and six outpatient surgery centers. It operated and managed physician networks in California, Colorado, Florida, Nevada, New Mexico, Pennsylvania and Washington and served approximately 1.7... Read More »
U.S. Renal Care Gets Big New Backers

U.S. Renal Care Gets Big New Backers

U.S. Renal Care has new owners, as of February 13. It marks the first renal-related transaction in 2019 and it won’t be the last. The national dialysis provider was backed by a consortium of private equity firms such as Leonard Green & Partners, Frazier Healthcare Partners, New Enterprise Associates and Cressey & Company. Stepping in to take over is Bain Capital Private Equity, Summit Partners and Revelstoke Partners, with participation by the company’s executive management team. Financial terms were not disclosed, naturally. U.S. Renal Care works with nephrologists to develop, acquire and operate outpatient treatment centers for people suffering from chronic kidney... Read More »
Physician Practices Kept Consolidating in Q2:18

Physician Practices Kept Consolidating in Q2:18

Investor interest in physician medical groups ramped up significantly in 2018, with 55 transactions announced in the first quarter, followed by 53 deals in the second quarter. The second quarter deals represent 29% of the total of 184 announced in the previous 12 months. Deal volume slipped 4% compared with the previous quarter but posted a 61% increase versus the same quarter a year earlier. Physicians in small practices have been under growing pressure from regulations and legislation, changes in reimbursement cycles and episodes of care. Under MACRA, they may be the lead provider when it comes to bundled payments, which makes primary care and hospital-based physicians of interest to... Read More »
New Enterprise Associates Adds Paladina Health to Its Portfolio

New Enterprise Associates Adds Paladina Health to Its Portfolio

New Enterprise Associates (NEA) has a strong healthcare portfolio, filled with digital health, population health management and physician practices. On June 6, the private equity firm added another physician group, Paladina Health, for a reported $100 million. It’s not surprising that the bidding was “highly competitive,” according to a CNBC source, and that there were other private equity firms in the process. What is interesting is the nod that “a large retailers and pharmacy chain” was also in the hunt. Hello, CVS Health (NYSE: CVS)? Paladina Health, a subsidiary of DaVita Inc. (NYSE: DVA), is a primary care practice with 53 clinics in 10 states. It... Read More »